Neoadjuvant chemotherapy with docetaxel plus oxaliplatin and S-1 for locally advanced, resectable gastric or gastro-esophageal junction adenocarcinoma: Short-term results from a phase II trial.

Tomono Kawase,Yukinori Kurokawa,Noboru Kobayashi,Atsushi Takeno,Ryohei Kawabata,Tsuyoshi Takahashi,Makoto Yamasaki,Yuichiro Doki

Neoadjuvant chemotherapy with docetaxel plus oxaliplatin and S-1 for locally advanced, resectable gastric or gastro-esophageal junction adenocarcinoma: Short-term results from a phase II trial.

2020

Tomono Kawase
Yukinori Kurokawa
Noboru Kobayashi
Atsushi Takeno
Ryohei Kawabata
Tsuyoshi Takahashi
Makoto Yamasaki
Yuichiro Doki

397Background: In locally advanced, resectable gastric or gastro-oesophageal junction (EGJ) adenocarcinoma, perioperative the docetaxel-based triplet FLOT (fluorouracil plus leucovorin, oxaliplatin...

Keywords:

Gastroenterology
Adenocarcinoma
Gastro-
Internal medicine
Oxaliplatin
Chemotherapy
Medicine
Docetaxel
Pathology
Fluorouracil
locally advanced
gastro esophageal junction
Perioperative

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations